^™middle.

Gathering signals...

Epiminder (ASX:EPI) — Material Events

ASX:EPI · 5 articles in the last 12 months · 100% assessed

Click a band to jump to that tier

Major ≥90 Significant 75–89 Notable 50–74 Routine <50 Not assessed

Significant Score 75–89

4

Epiminder Raises $125m, Launches US Implants and Expands DETECT StudyHigh

Epiminder lists on ASX, raises $125m, initiates US implants and DETECT study enrollment

28 Jan 2026 ·Quarterly Report and Appendix 4C ·85

Epiminder Raises $125m IPO, Accelerates US Rollout of Minder DeviceHigh

Epiminder raises $125m IPO, reports $21.7m half-year loss, advances Minder device commercialisation

25 Feb 2026 ·Interim Financial Report ·85

Epiminder Launches First US Minder Implant in Groundbreaking Epilepsy TrialMedium

Epiminder achieves first US implant of Minder System in major epilepsy monitoring trial

19 Jan 2026 ·Clinical Trial Update ·85

Epiminder Accelerates DETECT Study with 15 Patients Enrolled, Cash Reserves at $83.8mMedium

Epiminder accelerates DETECT study enrolment, maintains strong cash position, on track for 2028 commercial rollout

30 Apr 2026 ·Quarterly Activity and Cash Flow Report ·80

Notable Score 50–74

1

Epiminder Finalizes $15.77M R&D Tax Repayment, Retains $4.23M for GrowthMedium

Epiminder to repay $15.77M to ATO for historical R&D tax claims, retains $4.23M for working capital

17 Dec 2025 ·Regulatory Announcement ·60

Not Assessed Low Score, or missing data

0

No articles in this tier for the last 12 months.

Market Mentions 4 - appeared in market wrap coverage

These are market wrap articles where Epiminder (ASX:EPI) was mentioned. They reflect broader market coverage, not company-specific announcements.

Market Wrap - Week 9 (23 Feb -> 27 Feb) 2026

Healthcare Wrap - Week 9 (23 Feb -> 27 Feb) 2026

Healthcare Wrap - Week 5 (26 Jan -> 30 Jan) 2026

Healthcare Wrap - Week 4 (19 Jan -> 23 Jan) 2026